Search Result "disease modifyingdrugs"
Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer's Disease
Journal: Current Alzheimer Research
Volume: 17 Issue: 4 Year: 2020 Page: 324-328
Author(s): Matan B. Abou,Liang Sun,Huafeng Wei
Novel Therapeutic Targets in Neuropsychiatric Disorders: The Neuroepigenome
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 1 Year: 2014 Page: 1831-1839
Author(s): Lucio Tremolizzo, Virginia Rodriguez-Menendez, Elisa Conti, Chiara Paola Zoia, Guido Cavaletti, Carlo Ferrarese
Is it All Said for NSAIDs in Alzheimerâs Disease? Role of Mitochondrial Calcium Uptake
Journal: Current Alzheimer Research
Volume: 15 Issue: 6 Year: 2018 Page: 504-510
Author(s): Sara Sanz-Blasco,Maria Calvo-RodrÃguez,Erica Caballero,Monica Garcia-Durillo,Lucia Nunez,Carlos Villalobos
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 20 Year: 2019 Page: 3764-3774
Author(s): Damiana Scuteri,Laura Rombolá,Laura Tridico,Hirokazu Mizoguchi,Chizuko Watanabe,Tsukasa Sakurada,Shinobu Sakurada,Maria T. Corasaniti,Giacinto Bagetta,Luigi A. Morrone
18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: Chemical, Radiochemical, Biological and Clinical Features
Journal: Current Alzheimer Research
Volume: 14 Issue: 2 Year: 2017 Page: 178-185
Author(s): Shozo Furumoto,Tetsuro Tago,Ryuichi Harada,Yukitsuka Kudo,Nobuyuki Okamura
DLPF Targeted Repetitive Transcranial Magnetic Stimulation ImprovesBrain Glucose Metabolism Along with the Clinical and ElectrophysiologicalParameters in CBD Patients
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22 Issue: 4 Year: 2022 Page: 415-424
Author(s): Halil Aziz Velioglu
Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs
Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Volume: 12 Year: 2024
Author(s):
Doi: 10.2174/9789815179842124120003
Introduction: Advancing Drug Discovery for Alzheimers Disease [ ISOA Fifth Annual Investigators Meeting “Recent Advances in Drug Discovery and Development for Alzheimers Disease” Sponsored by Elan Pharmaceuticals Inc, The Graphic Expression, Glaxo Smith Kline Pharmaceuticals, Neurochem Inc, Pfizer Inc. (Guest Editors: Howard M. Fillit and Lorenzo M. Refolo)]
Journal: Current Alzheimer Research
Volume: 2 Issue: 2 Year: 2005 Page: 105-107
Author(s): Howard M. Fillit, Lorenzo M. Refolo
Neurogenic Molecules Modulating Cell Survival Pathways, Amyloid Beta, Tau Proteins, and Metal Dyshomeostasis: An Alternative Hope for Alzheimerâs Therapy
Ebook: Frontiers in Clinical Drug Research - Alzheimer Disorders
Volume: 1 Year: 2013
Author(s): Hailin Zheng,Mati Fridkin,Moussa B.H. Youdim
Doi: 10.2174/9781608057221113010009
Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 35 Year: 2021 Page: 7247-7277
Author(s): SÃlvia Chaves,Katalin Várnagy,M. Amélia Santos